• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马拉维的 COVID-19 疫苗快速接种策略:努力覆盖未接种人群。

COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach.

机构信息

UNICEF Country Office, Malawi.

Ministry of Health, Govt. of Malawi, Malawi.

出版信息

Vaccine. 2022 Aug 19;40(35):5089-5094. doi: 10.1016/j.vaccine.2022.07.014. Epub 2022 Jul 18.

DOI:10.1016/j.vaccine.2022.07.014
PMID:35871867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9291406/
Abstract

OBJECTIVES

To establish the impact of "Covid-19 Vaccination express" (CVE) on vaccine uptake in Malawi.

DESIGN

Retrospective cross-sectional study to compare the daily vaccine administration rate in CVE and routine covid vaccination (RCV). RCV data was collected from March 2021 to October 2021. The data regarding CVE was collected from 5 November 2021 to 31 December 2021. Data was collected regarding (1) the total number and type of vaccine doses administered and (2) Demographic details like age, gender, occupation, presence of comorbidities, the first dose, or the second dose of the people who received a vaccine.

RESULTS

From March-December 2021, a total of 1,866,623 COVID-19 vaccine doses were administered, out of which 1,290,145 doses were administered at a mean daily vaccination rate of 1854 (95 % CI: 1292-2415) doses as a part of RCV, and 576,478 doses were administered at a mean daily vaccination rate of 3312 (95 % CI: 2377-4248) doses as a part of CVE. Comparing the mean daily doses (Astra Zeneca, AZ doses 1 & 2) administered in the CVE and RCV showed that the mean daily doses of AZ vaccine administered were significantly higher in the CVE (p < 0.05).

CONCLUSION

CVE successfully increased the uptake of the Covid-19 vaccine.

摘要

目的

评估“Covid-19 疫苗快速接种”(CVE)对马拉维疫苗接种率的影响。

设计

回顾性横断面研究,比较 CVE 和常规新冠疫苗接种(RCV)的每日疫苗接种率。RCV 数据收集于 2021 年 3 月至 2021 年 10 月。CVE 数据收集于 2021 年 11 月 5 日至 2021 年 12 月 31 日。数据收集内容包括:(1)接种的疫苗总剂量和类型;(2)接种者的人口统计学细节,如年龄、性别、职业、是否存在合并症、首剂或第二剂疫苗接种情况。

结果

2021 年 3 月至 12 月期间,共接种了 1866623 剂新冠疫苗,其中 1290145 剂作为 RCV 的一部分,平均每日接种率为 1854 剂(95%CI:1292-2415),576478 剂作为 CVE 的一部分,平均每日接种率为 3312 剂(95%CI:2377-4248)。比较 CVE 和 RCV 中阿斯利康(AZ)疫苗 1 剂和 2 剂的平均每日剂量(Astra Zeneca, AZ doses 1 & 2),发现 CVE 中 AZ 疫苗的平均每日接种剂量明显更高(p<0.05)。

结论

CVE 成功提高了新冠疫苗的接种率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9291406/643f12b0b3d2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9291406/92abea366550/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9291406/643f12b0b3d2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9291406/92abea366550/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c77c/9291406/643f12b0b3d2/gr2_lrg.jpg

相似文献

1
COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach.马拉维的 COVID-19 疫苗快速接种策略:努力覆盖未接种人群。
Vaccine. 2022 Aug 19;40(35):5089-5094. doi: 10.1016/j.vaccine.2022.07.014. Epub 2022 Jul 18.
2
'Vaccinate my village' strategy in Malawi: an effort to boost COVID-19 vaccination.马拉维的“为我的村庄接种疫苗”策略:一项促进新冠疫苗接种的努力。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):180-185. doi: 10.1080/14760584.2023.2171398.
3
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.疫苗安全数据链接中 COVID-19 疫苗接种后吉兰-巴雷综合征的发生率。
JAMA Netw Open. 2022 Apr 1;5(4):e228879. doi: 10.1001/jamanetworkopen.2022.8879.
4
[Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].[对接种三剂科兴疫苗后以及在两剂科兴疫苗基础上接种一剂辉瑞疫苗的TOBB ETÜ医院工作人员的体液免疫和细胞免疫进行调查]
Mikrobiyol Bul. 2022 Jul;56(3):387-403. doi: 10.5578/mb.20229702.
5
Antibody responses to COVID-19 vaccines in older adults.老年人对 COVID-19 疫苗的抗体反应。
J Med Virol. 2022 Apr;94(4):1650-1654. doi: 10.1002/jmv.27531. Epub 2021 Dec 27.
6
Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana.撒哈拉以南非洲国家 COVID-19 疫苗融资:加纳全国支付意愿调查的经验教训。
BMC Public Health. 2022 Jun 30;22(1):1273. doi: 10.1186/s12889-022-13602-1.
7
Adverse effects following COVID-19 vaccination in Iran.伊朗 COVID-19 疫苗接种的不良反应。
BMC Infect Dis. 2022 May 18;22(1):476. doi: 10.1186/s12879-022-07411-5.
8
Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.新型 2019 冠状病毒病(COVID-19)疫苗在癫痫患者(PwE)中的安全性和耐受性:一项横断面研究。
Seizure. 2021 Nov;92:2-9. doi: 10.1016/j.seizure.2021.08.001. Epub 2021 Aug 6.
9
The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.辉瑞-生物科技和牛津-阿斯利康疫苗在哥斯达黎加预防重症 COVID-19 的有效性:全国范围内,住院率的生态学研究。
JMIR Public Health Surveill. 2022 May 20;8(5):e35054. doi: 10.2196/35054.
10
"This is most likely not the correct vaccine": Analyzing COVID-19's viral spread and vaccine anxieties in Ghana, Cameroon, and Malawi.“这很可能不是正确的疫苗”:分析加纳、喀麦隆和马拉维的 COVID-19 病毒传播和疫苗焦虑。
Soc Sci Med. 2023 Jul;329:116001. doi: 10.1016/j.socscimed.2023.116001. Epub 2023 May 31.

引用本文的文献

1
The cost of delivering COVID-19 vaccines in four districts in Malawi.在马拉维四个地区交付新冠疫苗的成本。
Cost Eff Resour Alloc. 2025 Jul 22;23(1):36. doi: 10.1186/s12962-025-00610-2.
2
Evaluating self-reported vaccination hesitancy in mobile phone surveys in low- and middle-income countries: learned lessons from Ethiopia, Indonesia, Kenya, and Malawi.评估低收入和中等收入国家手机调查中自我报告的疫苗接种犹豫情况:来自埃塞俄比亚、印度尼西亚、肯尼亚和马拉维的经验教训。
J Glob Health. 2025 May 23;15:04066. doi: 10.7189/jogh.15.04066.
3
COVID-19 severity and vaccine effectiveness in Malawi: A test-negative case-control study.

本文引用的文献

1
Identifying psychological antecedents and predictors of vaccine hesitancy through machine learning: A cross sectional study among chronic disease patients of deprived urban neighbourhood, India.通过机器学习识别疫苗犹豫的心理前因和预测因素:印度贫困城市社区慢性病患者的横断面研究。
Monaldi Arch Chest Dis. 2022 Mar 16;92(4). doi: 10.4081/monaldi.2022.2117.
2
End COVID-19 in low- and middle-income countries.在低收入和中等收入国家终结新冠疫情。
Science. 2022 Mar 11;375(6585):1105-1110. doi: 10.1126/science.abo4089. Epub 2022 Mar 10.
3
Depopulation or vaccination? Tackling the COVID-19 crisis in prisons in Africa.
马拉维的新冠病毒疾病严重程度及疫苗效力:一项检测呈阴性的病例对照研究。
J Public Health Afr. 2025 Apr 11;16(1):758. doi: 10.4102/jphia.v16i1.758. eCollection 2025.
4
COVID-19 vaccine uptake, barriers and associated factors among healthcare workers in Malawi.马拉维医护人员对新冠疫苗的接种情况、障碍及相关因素
J Public Health Afr. 2025 Feb 14;16(1):676. doi: 10.4102/jphia.v16i1.676. eCollection 2025.
5
Mortality risk information and health-seeking behavior during an epidemic.疫情期间的死亡率风险信息和寻医行为。
Proc Natl Acad Sci U S A. 2024 Jul 9;121(28):e2315677121. doi: 10.1073/pnas.2315677121. Epub 2024 Jul 3.
6
Knowledge, attitudes and demographic drivers for COVID-19 vaccine hesitancy in Malawi.马拉维民众对 COVID-19 疫苗犹豫的知识、态度和人口统计学驱动因素。
Sci Rep. 2024 Apr 26;14(1):9578. doi: 10.1038/s41598-024-60042-5.
人口减少还是接种疫苗?应对非洲监狱中的新冠疫情危机
Health Justice. 2022 Mar 5;10(1):12. doi: 10.1186/s40352-022-00176-8.
4
Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.非洲 COVID-19 疫苗接种率低:当前证据和前进道路。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2034457. doi: 10.1080/21645515.2022.2034457. Epub 2022 Mar 3.
5
Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.低收入国家接种 COVID-19 疫苗的意愿:来自埃塞俄比亚的证据。
PLoS One. 2022 Mar 3;17(3):e0264633. doi: 10.1371/journal.pone.0264633. eCollection 2022.
6
Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy.全球在 COVID-19 疫苗接种妊娠应用的公共卫生指导方面存在差异。
BMJ Glob Health. 2022 Feb;7(2). doi: 10.1136/bmjgh-2021-007730.
7
The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行:我们对该病毒流行病学和传播动态的理解中仍然存在的不确定性,以及有待克服的挑战。
Interface Focus. 2021 Oct 12;11(6):20210008. doi: 10.1098/rsfs.2021.0008. eCollection 2021 Dec 6.
8
A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries.对中低收入国家 COVID-19 疫苗接受度的决定因素和策略的快速证据综述。
J Glob Health. 2021 Nov 20;11:05027. doi: 10.7189/jogh.11.05027. eCollection 2021.
9
COVID-19 Vaccine Hesitancy in the United States: A Systematic Review.美国的 COVID-19 疫苗犹豫:系统评价。
Front Public Health. 2021 Nov 23;9:770985. doi: 10.3389/fpubh.2021.770985. eCollection 2021.
10
Vaccine equity: a stress test for planetary health.疫苗公平性:对全球健康的压力测试。
Lancet Planet Health. 2021 Nov;5(11):e758-e759. doi: 10.1016/S2542-5196(21)00291-6.